» Articles » PMID: 2522421

CD8+ T Cells Inhibit Plasmodium Falciparum-induced Lymphoproliferation and Gamma Interferon Production in Cell Preparations from Some Malaria-immune Individuals

Overview
Journal Infect Immun
Date 1989 Apr 1
PMID 2522421
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Infection with Plasmodium falciparum induces marked disturbances in normal immunoregulatory functions. Antigen-specific immunosuppression is a feature of acute malaria and has been linked to activation of CD8+ T suppressor cells. Among immune adults, cell-mediated immune responses to malaria antigens are extremely variable when measured in vitro, and there is no obvious relation between responsiveness and resistance to clinical disease. In this study, when CD8+ cells were removed from peripheral blood mononuclear cell preparations obtained from individuals who responded poorly to a soluble malaria antigen preparation, both lymphoproliferation and gamma interferon production were significantly enhanced, but responses to other soluble antigens and mitogen were unaffected. No effect of CD8+ cell depletion was seen in individuals whose undepleted mononuclear cells gave a high response to the malaria antigen. This suggests that for some malaria-exposed individuals, CD8+ cells activated in vitro by exposure to malaria antigens suppress other cellular responses and may obscure the presence of potentially protective immune mechanisms.

Citing Articles

Pathogenic Th1 responses in CHIKV-induced inflammation and their modulation upon Plasmodium parasites co-infection.

Torres-Ruesta A, Teo T, Chan Y, Renia L, Ng L Immunol Rev. 2019; 294(1):80-91.

PMID: 31773780 PMC: 7064921. DOI: 10.1111/imr.12825.


Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea.

Robinson L, DOmbrain M, Stanisic D, Taraika J, Bernard N, Richards J Infect Immun. 2009; 77(7):3033-43.

PMID: 19380468 PMC: 2708537. DOI: 10.1128/IAI.00211-09.


Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function.

Millington O, Di Lorenzo C, Stephen Phillips R, Garside P, Brewer J J Biol. 2006; 5(2):5.

PMID: 16611373 PMC: 1561486. DOI: 10.1186/jbiol34.


Lymphoproliferative responses to a merozoite surface antigen of Plasmodium falciparum: preliminary evidence for seasonal activation of CD8+/HLA-DQ-restricted suppressor cells.

Riley E, Morris-Jones S, Taylor-Robinson A, Holder A Clin Exp Immunol. 1993; 94(1):64-7.

PMID: 8403519 PMC: 1534374. DOI: 10.1111/j.1365-2249.1993.tb05978.x.


Increased plasma levels of soluble IL-2R are associated with severe Plasmodium falciparum malaria.

Jakobsen P, Morris-Jones S, Theander T, Hviid L, Hansen M, Bendtzen K Clin Exp Immunol. 1994; 96(1):98-103.

PMID: 8149674 PMC: 1534535. DOI: 10.1111/j.1365-2249.1994.tb06237.x.


References
1.
McBride J, Micklem H, Ure J . Immunosuppression in murine malaria. I. Response to type III pneumococcal polysaccharide. Immunology. 1977; 32(5):635-44. PMC: 1445332. View

2.
Riley E, Andersson G, Otoo L, Jepsen S, Greenwood B . Cellular immune responses to Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria. Clin Exp Immunol. 1988; 73(1):17-22. PMC: 1541481. View

3.
Weinbaum F, Weintraub J, Nkrumah F, Evans C, Tigelaar R, Rosenberg Y . Immunity to Plasmodium berghei yoelii in mice. II. Specific and nonspecific cellular and humoral responses during the course of infection. J Immunol. 1978; 121(2):629-36. View

4.
Lelchuk R, Sprott V, Playfair J . Differential involvement of non-specific suppressor T cells in two lethal murine malaria infections. Clin Exp Immunol. 1981; 45(2):433-8. PMC: 1537370. View

5.
Druilhe P, Canivet M, Gentilini M, Peries J . Circulating interferon in patients with Plasmodium falciparum, P. ovale and P. vivax malaria. Trans R Soc Trop Med Hyg. 1982; 76(3):422-3. DOI: 10.1016/0035-9203(82)90207-3. View